Drugs Made In America Acquisition Corp. (DMAAR)New York, United States | NasdaqGM
0.12 USD
0.00
(-0.084%) ⇩
(Oct. 15, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 5:20 a.m. EDT
The security is trading at a negligible price of $0.1275 against a massive debt load of $350,000, creating a precarious balance sheet with a current ratio of merely 0.023. Operating cash flow is deeply negative at -$517,145, indicating severe liquidity distress. The business shows deteriorating fundamentals with quarterly earnings growth plummeting by 24.5%. There is no price history available to assess long-term trends, and the company offers no dividend income whatsoever. This profile suggests a high-risk speculative vehicle rather than a viable investment. |
| Attribute | Value |
|---|---|
| Address1 | 420 Lexington Avenue |
| Address2 | Suite 1402 |
| Ask | 0.16 |
| Ask Size | 1 |
| Bid | 0.0904 |
| Bid Size | 1 |
| Book Value | -0.305 |
| City | New York |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.1196 |
| Current Ratio | 0.023 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.1199 |
| Day Low | 0.1073 |
| Display Name | Drugs Made In America |
| Earnings Growth | -0.179 |
| Earnings Quarterly Growth | -0.245 |
| Earnings Timestamp End | 1,747,771,200 |
| Earnings Timestamp Start | 1,747,771,200 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.1199 |
| Fifty Two Week High Change | -0.00030000508 |
| Fifty Two Week High Change Percent | -0.0025021273 |
| Fifty Two Week Low | 0.1073 |
| Fifty Two Week Low Change | 0.0123 |
| Fifty Two Week Low Change Percent | 0.11463187 |
| Fifty Two Week Range | 0.1073 - 0.1199 |
| Financial Currency | USD |
| Float Shares | 19,788,112 |
| Full Exchange Name | NasdaqGM |
| Fullday Change | -0.00010000169 |
| Fullday Change Percent | -0.083543606 |
| Fullday Price | 0.1196 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,025-02-25 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Long Business Summary | Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York. |
| Long Name | Drugs Made In America Acquisition Corp. |
| Market | us_market |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1889535116 |
| Net Income To Common | 6,094,877 |
| Open | 0.1074 |
| Operating Cashflow | -517,145 |
| Operating Margins | 0.0 |
| Phone | 646 726 7074 |
| Previous Close | 0.1197 |
| Price Hint | 4 |
| Price To Book | -0.39213112 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.007 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00010000169 |
| Regular Market Change Percent | -0.083543606 |
| Regular Market Day High | 0.1199 |
| Regular Market Day Low | 0.1073 |
| Regular Market Day Range | 0.1073 - 0.1199 |
| Regular Market Open | 0.1074 |
| Regular Market Previous Close | 0.1197 |
| Regular Market Price | 0.1196 |
| Regular Market Time | 1,792,094,400 |
| Regular Market Volume | 29,870 |
| Sand P52 Week Change | 0.16207206 |
| Sector | |
| Sector Key | |
| Shares Outstanding | 20,400,000 |
| Short Name | Drugs Made In America Acquisiti |
| Source Interval | 15 |
| State | NY |
| Symbol | DMAAR |
| Total Cash | 20,280 |
| Total Cash Per Share | 0.001 |
| Total Debt | 350,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 29,870 |
| Zip | 10,170 |